Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology

Consumption, Tobacco Clinical Trial

Official title:

INFO-AIDE-TABAC Study on the Level of Information on the Risks Related to Tobacco of Persons Consulting in Psychiatry and on Access to Aids in Case of Smoking, Comparing With Persons Consulting in Diabetology or in Addictology

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT04333030
• Other study ID #: P19/12_info_aide_tabac
• Status: Completed
• Start date: August 12, 2019
• Est. completion date: December 31, 2020

Study information

• Verified date: August 2021
• Source: Versailles Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

this is an observational study that involves providing a questionnaire to patients consulting in psychiatry, addictology (other than tobacco) and endocrinology to assess their knowledge of tobacco risks and access to smoking cessation aids

Recruitment information / eligibility

• Status: Completed
• Enrollment: 310
• Est. completion date: December 31, 2020
• Est. primary completion date: June 30, 2020
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patients > 18 years

• Men and women

• who comes for consultation during the study

• Psychiatry on CMP or HDJ, regardless of diagnosis or smoking status

• Endocrinology in consultation or HDJ

• In addictology at CSAPA

Exclusion Criteria:

• Patient unable to complete questionnaire (not speaking French, confused, alcoholics, etc.)

• Refusal to complete questionnaire

Related Conditions & MeSH terms

• Consumption, Tobacco

Intervention

Other:
• questionnaire
Tobacco Use and Risk Questionnaire

Locations

Country	Name	City	State
France	Centre Hospitalier de Versailles	Le Chesnay
France	Hôpital Ferdinand Widal	Paris

Sponsors (1)

Lead Sponsor	Collaborator
Versailles Hospital

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	to Assess the level of information on tobacco-related risks of patients with questionnaire	to Assess the level of information on tobacco-related risks of patients monitored for psychiatric disorders by comparing them to patients monitored for an addiction other than tobacco or to patients monitored for a chronic disease	at the end of study, average 2 month
Primary	to Assess access to smoking cessation aids for smokers and ex-smokers with questionnaire	to Assess access to smoking cessation aids for smokers and ex-smokers among psychiatric patients compared to smokers and ex-smokers among patients who have been monitored for an addiction other than tobacco or among patients who have been monitored for a chronic disease (endocrine).	at the end of study, average 2 month